Of timing and surrogates: a way forward for cancer chemoprevention.
Where this comes from
- Record sourced from PubMed, PMID 21498391.
- Also identified by DOI 10.1158/1078-0432.CCR-11-0643 and PMC identifier 3574815.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cancer chemoprevention strategies are not widely implemented in clinical practice. Targeting biomarkers in patients with elevated risk of developing cancer by means of short-term administration of certain agents may be a strategy to minimize toxicities while maintaining efficacy in clinical trials that can be completed in years rather than decades.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Antineoplastic Agents
- Colorectal Neoplasms